Login / Signup

Unveiling potential adverse events associated with escitalopram oxalate: A real-world analysis based FDA adverse event reporting system database.

Ying JiangYusi ChengZhiqiang DuYuan ShenQin ZhouYingying JiHaohao Zhu
Published in: Journal of psychopharmacology (Oxford, England) (2024)
While escitalopram oxalate has clear benefits in the treatment of depression and other mental health disorders, the presence of AEs also suggests risks associated with its use. Particularly concerning are risks of suicide and changes in serum serotonin levels.
Keyphrases
  • mental health
  • human health
  • adverse drug
  • major depressive disorder
  • risk assessment
  • depressive symptoms
  • mental illness
  • emergency department
  • climate change
  • sleep quality
  • physical activity
  • electronic health record